Hometown Urgent Care in Ohio is one of just 18 sites participating in a new phase 3 clinical trial to assess a prospective treatment for adult patients with acute migraines. The trial will compare pain freedom in subjects who’ve taken the drug rimegepant vs placebo in the acute treatment of migraine at 2 hours postdose. It will also take into account freedom from the “most bothersome symptom” (nausea, phonophobia, or photophobia) in the rimegepant group …
Read More![Phase 3 Migraine Clinical Trial Finds a Prime Site in Urgent Care Phase 3 Migraine Clinical Trial Finds a Prime Site in Urgent Care](https://www.jucm.com/wp-content/uploads/2018/03/Phase-3-Migraine-image-2.jpg)